Inhibitory effect of extracts from edible parts of nuts on α-amylase activity: a systematic review

Mena Farazi,Michael J. Houghton,Barbara R. Cardoso,Margaret Murray,Gary Williamson

DOI: https://doi.org/10.1039/d4fo00414k

IF: 6.3173

2024-05-09

Food & Function

Abstract:Elevated blood glucose concentration is a risk factor for developing metabolic dysfunction and insulin resistance, leading to type 2 diabetes and cardiovascular diseases. Nuts have the potential to inhibit α-amylase activity, and so lower postprandial glucose, due to their content of polyphenols and other bioactive compounds. We conducted a systematic literature review to assess the ability of extracts from commonly consumed edible parts of nuts to inhibit α-amylase. Among the 31 included papers, only four utilised human α-amylases. These papers indicated that polyphenol-rich chestnut skin extracts exhibited strong inhibition of both human salivary and pancreatic α-amylases, and that a polyphenol-rich almond skin extract was a potent inhibitor of human salivary α-amylase. The majority of the reviewed studies utilised porcine pancreatic α-amylase, which has ∼86% sequence homology with the corresponding human enzyme but with some key amino acid variations located within the active site. Polyphenol-rich extracts from chestnut, almond, kola nut, pecan and walnut, and peptides isolated from cashew, inhibited porcine pancreatic α-amylase. Some studies used α-amylases sourced from fungi or bacteria, outcomes from which are entirely irrelevant to human health, as they have no sequence homology with the human enzyme. Given the limited research involving human α-amylases, and the differences in inhibition compared to porcine enzymes and especially enzymes from microorganisms, it is recommended that future in vitro experiments place greater emphasis on utilising enzymes sourced from humans to facilitate a reliable prediction of effects in intervention studies.

biochemistry & molecular biology,food science & technology

What problem does this paper attempt to address?

This paper mainly discusses the inhibitory effects of extracts from edible nuts on α-amylase activity, in order to reduce postprandial blood glucose concentration, and may contribute to the prevention and management of type 2 diabetes and cardiovascular diseases. The research team conducted a systematic literature review and analyzed 31 relevant studies, of which only four used human α-amylase. The results showed that the extracts from chestnut peel and almond peel, which are rich in polyphenols, significantly inhibited both human α-amylase. Most studies used porcine pancreatic α-amylase, which has higher sequence homology with human enzymes but still has differences. Some studies also used α-amylases from microorganisms, which are not relevant to human health.

The paper points out that considering the limited research involving human α-amylase, future in vitro experiments should use enzymes derived from humans more to more accurately predict the effects of intervention studies. The study also emphasizes the differences in inhibitory effects when using α-amylases from different sources, and suggests further attention to compounds in foods that have similar effects to acarbose but with fewer side effects.